$OSCR Crushes Q2 Estimates and Raises Full-Year Outlook 🚀

Oscar Health delivered a major Q2 beat:
Revenue: $4.9B vs. $4.75B estimated
EPS: $1.10 vs. $0.39 estimated
Adjusted EBITDA: $415.3M vs. $188M estimated
Net income: $361.8M vs. $156M estimated
Medical loss ratio: 79.2% , down 1,190 basis points YoY
SG&A expense ratio: 14.2% , down 450 basis points YoY
For FY2026, $OSCR expects revenue of $18.7B–$19.0B and operating income of $500M–$700M , well above the $399M consensus estimate.
Management credited strong execution and improving fundamentals across the individual health insurance market.